Patterns of Tyrosine and Tryptophan Metabolites in Controls and Various Degenerative Disorders
Over the last few years, we have been applying techniques for generating and analyzing complex patterns of several hundred small biological molecules to neurodegenerative disorders. The general hypothesis emerging from this work is that patterns of small molecular species are an operational expression of the genome. Under this hypothesis, we would argue that: (1) the underlying genetic makeup of an individual determining their variability in such features as morphology and patterns of enzymes will be reflected through these features in the levels and interrelationships of small molecular species such as transmitters, precursors, metabolites, cofactors; and (2) an individual with a particular degenerative or affective disorder will exhibit a pattern of small molecules that is uniquely different from both normals and other disorders.
KeywordsKynurenic Acid Linear Multiple Regression Homogentisic Acid Tryptophan Metabolite Small Biological Molecule
Unable to display preview. Download preview PDF.
- 1.Beal MF, Matson WR, Swartz KJ, Gamache PH and Bird ED. Kynurenine Pathway Measurements in Huntington’s Disease Striatum; Evidence for Reduced Formation of Kynurenic Acid. J. Neurochemistry, submitted.Google Scholar
- 2.Swartz KY, Matson WR, MacGarvey U and Beal MF. Measurement of Kynurenic Acid in Mammalian Brain Extracts and Cerebral Spinal Fluid by High Performance Liquid Chromatography with Fluorescence Detection. J. Neurochemistry, submitted.Google Scholar
- 3.Bouckoms AJ, Sweet WH, Poletti C, Lavori P, Carr D, Matson W, Gamache PHand Aronin N. Monoamines in the Brain Cerebrospinal Fluid of Facial Pain Patients. Anesthesia, submitted.Google Scholar